学校法人順天堂　研究者情報データベース:::研究業績詳細:::

HOME　＞　研究業績詳細

研究業績詳細

飯嶋賢一（イイジマケンイチ）

研究テーマ	循環器内科学、心臓電気生理学、医用工学
研究業績（論文）	1. Fujiki S, Iijima K, Nakagawa Y, Takahashi K, Okabe M, Kusano K, Owada S, Kondo Y, Tsujita K, Shimizu W, Tomita H, Watanabe M, Shoda M, Watanabe M, Tokano T, Murohara T, Kaneshiro T, Kato T, Hayashi H, Maemura K, Niwano S, Umemoto T, Yoshida H, Ota K, Tanaka T, Kitamura N, Node K, Minamino T; EMPA ICD investigators.　Effect of empagliflozin on ventricular arrhythmias in patients with type 2 diabetes treated with an implantable cardioverter-defibrillator: the EMPA-ICD trial. Cardiovasc Diabetol. 2024;23:224-. 2. Ikami Y, Izumi D, Fujiki S, Sugiura H, Otsuki S, Suzuki N, Sakaguchi Y, Hakamata T, Hasegawa Y, Yagihara N, Iijima K, Tanaka T, Ishizawa M, Chinushi M, Minamino T, Inomata T. Differences in coagulation responses to vascular injury between uninterrupted dabigatran and apixaban - a clinical prospective randomized study. Heart Rhythm. 2024:S1547-5271 3. Sakaguchi Y, Izumi D, Wada R, Akagawa R, Suzuki N, Hakamata T, Ikami Y, Hasegaw Y, Otsuki S, Yagihara N, Iijima K, Inomata T. Predictors of long-term survival in Japanese patients with heart failure with reduced ejection fraction (HFrEF) treated with cardiac resynchronization therapy-defibrillators (CRT-D). Pacing Clin Electrophysiol. 2023;46:1484-1490. 4. Suzuki N, Otsuki S, Izumi D, Akagawa R, Sakaguchi Y, Hakamata T, Ikami Y, Hasegawa Y, Yagihara N, Iijima K, Chinushi M, Inomata T. Clinical impact of nocturnal ventricular tachyarrythmias in electrical storm. Pacing Clin Electrophysiol. 2022;45:1330-1337. 5. Hakamata T, Otsuki S, Izumi D, Sakaguchi Y, Suzuki N, Ikami Y, Hasegawa Y, Yagihara N, Iijima K, Chinushi M, Fuse K, Inomata T. Clinical impact of ECG changes on oversensing of subcutaneous implantable cardioverter-defibrillators. Heart Rhythm. 2022;19:1704-1711 6. Ikami Y, Izumi D, Hasegawa Y, Suzuki N, Sakaguchi Y, Hakamata T, Otsuki S, Yagihara N, Iijima K, Kashimura T, Chinushi M, Minamino T, Inomata T. The Risk of Ventricular Tachyarrhythmias in Patients with Antimitochondrial Antibodies-Related Noncardiac Diseases. Int Heart J. 2022;63:476-485. 7. Otsuki S, Izumi D, Sakaguchi Y, Suzuki N, Hakamata T, Ikami Y, Hasegawa Y, Yagihara N, Iijima K, Chinushi M, Minamino T, Takayuki I.　Efficacy of antitachycardia pacing alert by remote monitoring of implantable cardioverter-defibrillators for out-of-hospital electrical storm. Pacing Clin Electrophysiol. 2021;44:1675-1682. 8. Hasegawa Y, Watanabe H, Ikami Y, Otsuki S, Iijima K, Yagihara N, Izumi D, Minamino T. Response of the authors regarding article "J point elevation in high precordial leads associated with risk of ventricular fibrillation". Ann Noninvasive Electrocardiol. 2021;26:e12871. 9. Hasegawa Y, Izumi D, Ikami Y, Otsuki S, Yagihara N, Iijima K, Chinushi M, Minamino T. Progressive increase in activation delay during premature stimulation is related to ventricular fibrillation in Brugada syndrome. J Cardiovasc Electrophysiol. 2021;32:1939-1946. 10. Iijima K, Zhang H, Strachan MT, Huang J, Walcott GP, Rogers JM. The right ventricular insertion promotes the reinitiation of ventricular fibrillation in defibrillation failure. Heart Rhythm. 2021: S1547-5271(21)00053-9. doi: 10.1016/j.hrthm.2021.01.022. 11. Hasegawa Y, Watanabe H, Ikami Y, Otsuki S, Iijima K, Yagihara N, Izumi D, Minamino T. J point elevation in high precordial leads associated with risk of ventricular fibrillation. Ann Noninvasive Electrocardiol. 2021; 26: e12820. doi: 10.1111/anec.12820. 12. Matsuo Y, Yoshimine F, Fuse K, Suzuki K, Sakamoto T, Iijima K, Ozaki K, Minamino T. Regional disparity in guideline adherence for treatment of chronic heart failure. Intern Med. 2021;60(4):525-532. 13. Fujiki S, Iijima K, Okabe M, Niwano S, Tsujita K, Naito S, Ando K, Kusano K, Kato R, Nitta J, Miura T, Mitsuhashi T, Kario K, Kondo Y, Ieda M, Hagiwara N, Murohara T, Takahashi K, Tomita H, Takeishi Y, Anzai T, Shimizu W, Watanabe M, Morino Y, Kato T, Tada H, Nakagawa Y, Yano M, Maemura K, Kimura T, Yoshida H, Ota K, Tanaka T, Kitamura N, Node K, Aizawa Y, Shimizu I, Izumi D, Ozaki K, Minamino T. On behalf of the EMPA-ICD investigators. Placebo-controlled, double-blind study of empagliflozin (EMPA) and implantable cardioverter-defibrillator (EMPA-ICD) in patients with type 2 diabetes (T2DM): rationale and design. Diabetes Therapy. 2020; 11: 2739-2755 14. Otsuki S, Izumi D, Hasegawa Y, Yagihara N, Iijima K, Minamino T. Suppression of cardiac memory-related severe form of torsades de pointes by landiolol in a patient with congenital long QT syndrome type 2. HeartRhythm Case Rep. 2020; 6: 407-410 15. Furukawa K, Suzuki T, Ishiguro H, Morikawa H, Sonoda K, Iijima K, Ito M, Hanyu O, Sone H. Prevention of postprandial hypotension-related syncope by caffeine in a patient with long-standing diabetes mellitus. Endocr J. 2020. doi: 10.1507/endocrj.EJ19-0370. 16. Sato A, Hasegawa Y, Haniu H, Shiraishi S, Yagihara N, Iijima K, Izumi D, Minamino T. Replacement of an Implantable Cardioverter-Defibrillator (ICD) with a New Standard Subcutaneous ICD System in a Patient with Jervell and Lange-Nielsen Syndrome. Int Heart J. 2019. doi: 10.1536/ihj.19-076. [Epub ahead of print] 17. Hasegawa Y, Watanabe H, Ikami Y, Otsuki S, Iijima K, Yagihara N, Sato A, Izumi D, Minamino T. Early repolarization and risk of lone atrial fibrillation. J Cardiovasc Electrophysiol. 2019;30:565-568. 18. Sato A, Yagihara N, Hasegawa Y, Otuki S, Iijima K, Izumi D, Minamino T. A Steam Pop Detected by Intracardiac Echocardiography During Catheter Ablation of the Left Ventricular Papillary Muscle. Int Heart J. 2019;60:199-203. 19. Takano T, Tanaka K, Ozaki K, Sato A, Iijima K, Yanagawa T, Izumi D, Ozawa T, Fuse K, Sato M, Tanabe N, Minamino T. Clinical Predictors of Recurrent Ventricular Arrhythmias in Secondary Prevention Implantable Cardioverter Defibrillator Recipients With Coronary Artery Disease　- Lower Left Ventricular Ejection Fraction and Incomplete Revascularization. Circ J. 2018;82:3037-3043. 20. Otuki S, Izumi D, Suda M, Sato A, Hasegawa Y, Yagihara N, Iijima K, Chinushi M, Fuse I, Minamino T.　Effects of Direct Oral Anticoagulants at the Peak Phase, Trough Phase, and After Vascular Injury. J Am Coll Cardiol. 2018;71:102-104. 21. Iijima K, Ishida N, Izumi D, Minamino T. Inappropriate inhibition of biventricular pacing due to diaphragmatic myopotentials amplified by the selectable sensing filter. Europace. 2017.doi: 10.1093/europace/euw372. 22. Otuki S, Hasegawa K, Watanabe H, Katsuumi G, Yagihara N, Iijima K, Sato A, Izumi D, Furushima H, Chinushi M, Aizawa Y, Minamino T. The effects of pure potassium channel blocker nifekalant and sodium channel blocker mexiletine on malignant ventricular tachyarrhythmias. J Electrocardiol. 2017;50:277-281. 23. Zhang H, Iijima K, Huang J, Walcott GP, Rogers JM. Optical Mapping of Membrane Potential and Epicardial Deformation in Beating Hearts. Biophys J. 2016;111:438-451. 24. Chinushi M, Suzuki K, Saitoh O, Furushima H, Iijima K, Izumi D, Sato A, Sugai M, Iwafuchi M. Electrical stimulation-based evaluation for functional modification of renal autonomic nerve activities induced by catheter ablation. Heart Rhythm. 2016;13:1707-1715. 25. Iijima K, Chinushi M, Saitoh O, Hasegawa K, Sonoda K, Yagihara N, Sato A, Izumi D, Watanabe H, Furushima H, Aizawa Y, Minamino T. Frequency characteristics and associations with the defibrillation threshold of ventricular fibrillation in patients with implantable cardioverter defibrillators. Intern Med. 2015;54:1175-1182. 26. Chinushi M, Izumi D, Iijima K, Suzuki K, Furushima H, Saitoh O, Furuta Y, Aizawa Y, Iwafuchi M. Blood pressure and autonomic responses to electrical stimulation of the renal arterial nerves before and after ablation of the renal artery. Hypertension. 2013;61(2):450-456 27. Chinushi M, Iijima K, Sato A, Furushima H. Short-coupling premature ventricular complexes from the left ventricle triggered isoproterenol-resistant electrical storm in a patient with Brugada syndrome. Heart Rhythm. 2013;10:916-920. 28. Sato A, Chinushi M, Iijima K, Izumi D, Furushima H.　Insulation Defects in Riata Implantable Cardioverter-defibrillator Leads.　Intern Med. 2012;51:2689-2694. 29. Sato A, Chinushi M, Suzuki H, Numano F, Hanyu T, Iijima K, Watanabe H, Furushima H. Long QT Syndrome with Nocturnal Cardiac Events Caused by a KCNH2 Missense Mutation (G604S). Intern Med. 2012;51:1857-1860. 30. Chinushi M, Sato A, Iijima K, Suzuki K, Hiroshi F, Izumi D, Watanabe H, Kanae H, Aizawa Y. Exercise-Related QT Interval Shortening with a Peaked T Wave in a Healthy Boy with a Family History of Sudden Cardiac Death. Pacing Clin Electrophysiol. 2012;35:e239-242. 31. Iijima K, Chinushi M, Furushima H, Aizawa Y. Epicardial and endocardial mapping determine most successful site of ablation for ventricular tachyarrhythmias originating from left ventricular summit. Europace. 2012;14:911-912. 32. Furushima H, Chinushi M, Iijima K, Hasegawa K, Sato A, Izumi D, Watanabe H, Aizawa Y. Is the coexistence of sustained ST-segment elevation and abnormal Q waves a risk factor for electrical storm in implanted cardioverter defibrillator patients with structural heart diseases? Europace. 2012;14:675-681. 33. Izumi D, Chinushi M, Iijima K, Furushima H, Hosaka Y, Hasegawa K, Aizawa Y. The peak-to-end of the T wave in the limb ECG leads reflects total spatial rather than transmural dispersion of ventricular repolarization in an anthopleurin-A model of prolonged QT interval. Heart Rhythm. 2012;9:796-803. 34. Sato A, Chinushi M, Iijima K, Watanabe H, Izumi D, Furushima H, Sonoda K, Hasegawa K, Yagihara N, Aizawa Y. An appropriate defibrillation threshold obtained by the combined connection between two shock leads and ICD generator. Intern Med. 2011;50:2815-2818. 35. Sato A, Tanabe Y, Chinushi M, Hayashi Y, Yoshida T, Ito E, Izumi D, Iijima K, Yagihara N, Watanabe H, Furushima H, Aizawa Y. Analysis of J waves during myocardial ischaemia. Europace. 2012;14:715-723. 36. Furushima H, Chinushi M, Iijima K, Izumi D, Hosaka Y, Aizawa Y. Relationship between electroanatomical voltage mapping characteristics and breakout site of ventricular activation in idiopathic ventricular tachyarrhythmia originating from the right ventricular outflow tract septum. J Interv Card Electrophysiol. 2012;33:135-141. 37. Iijima K, Chinushi M, Furushima H, Aizawa Y. Intramural inflammation as a cause of transient ST-segment elevation in a patient of cardiac sarcoidosis. Europace. 2012;14:300-302. 38. Chinushi M, Furushima H, Hosaka Y, Komura S, Sato A, Iijima K, Aizawa Y. Endocardial arrhythmogenic mechanisms of torsades de pointes in patients with the congenital long QT syndrome. Intern Med. 2011;50:1695-1702. 39. Yagihara N, Sato A, Iijima K, Izumi D, Furushima H, Watanabe H, Irie T, Kaneko Y, Kurabayashi M, Chinushi M, Satou M, Aizawa Y. The prevalence of early repolarization in Wolff-Parkinson-White syndrome with a special reference to J waves and the effects of catheter ablation. J Electrocardiol. 2012;45:36-42. 40. Chinushi M, Izumi D, Furushima H, Sato A, Iijima K, Hasegawa K, Aizawa Y. Epicardial scar in a patient with no apparent heart disease. Pacing Clin Electrophysiol. 2012;35:e136-139. 41. Iijima K, Chinushi M, Hasegawa K, Izumi D, Hosaka Y, Furushima H, Aizawa Y. Inappropriate pacing inhibition triggered by QT prolongation due to T wave oversensing in an ICD recipient presenting with long QT syndrome. Intern Med. 2011;50:1021-1024. 42. Chinushi M, Hasegawa K, Iijima K, Furushima H, Izumi D, Sato A, Aizawa Y. Characteristics of j wave-associated idiopathic ventricular fibrillation: role of drugs. Pacing Clin Electrophysiol. 2012;35:e226-230. 43. Tagawa M, Chinushi M, Nakamura Y, Ochiai Y, Sato A, Iijima K, Uchiyama H, Furushima H, Aizawa Y. Recurrence of ventricular fibrillation in a patient with non-type 1 Brugada electrocardiographic morphology. J Cardiol Cases. 2012;6:e17-e19. 44. Chinushi M, Iijima K. Rate control is a better initial treatment for patients with atrial fibrillation and heart failure--rhythm control vs. rate control: which is better in the management of atrial fibrillation? (Rate-side). Circ J. 2011;75:970-978. 45. Chinushi M, Iijima K, Furushima H, Izumi D, Sato A, Yagihara N, Hasegawa K, Watanabe H, Soejima K, Aizawa Y. Suppression of Storms of Ventricular Tachycardia by Epicardial Ablation of Isolated Delayed Potential in Noncompaction Cardiomyopathy. Pacing Clin Electrophysiol. 2011 [Epub ahead of print] 46. Iijima K, Chinushi M, Izumi D, Aizawa Y. Ventricular tachycardia due to intramyocardial fibroma. J Cardiovasc Electrophysiol. 2011;22:825-826. 47. Izumi D, Chinushi M, Iijima K, Ahara S, Komura S, Furushima H, Hosaka Y, Sanada A, Yagihara N, Aizawa Y. Effects of bepridil versus E-4031 on transmural ventricular repolarization and inducibility of ventricular tachyarrhythmias in the dog. Pacing Clin Electrophysiol. 2010;33:950-999. 48. Furushima H, Chinushi M, Iijima K, Sanada A, Izumi D, Hosaka Y, Aizawa Y. Ventricular tachyarrhythmia associated with hypertrophic cardiomyopathy: incidence, prognosis, and relation to type of hypertrophy. J Cardiovasc Electrophysiol. 2010;21:991-999. 49. Iijima K, Chinushi M, Izumi D, Ahara S, Furushima H, Komura S, Hosaka Y, Sanada A, Sato A, Aizawa Y. Effect of bepridil in atrial fibrillation inducibility facilitated by vagal nerve stimulation. - Prevention of vagal nerve activation-induced shortening of the atrial action potential duration -. Circ J. 2010;74:895-902. 50. Komura S, Chinushi M, Furushima H, Hosaka Y, Izumi D, Iijima K, Watanabe H, Yagihara N, Aizawa Y. Efficacy of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia. Circ J. 2010;74:864-869. 51. Chinushi M, Hosaka Y, Okada S, Iijima K, Furushima H, Aizawa Y. Delayed pericardial effusion due to perforation of the right ventricular outflow tract by an ICD lead. Intern Med. 2010;49:389-392. 52. Hosaka Y, Chinushi M, Iijima K, Sanada A, Furushima H, Aizawa Y. Correlation between surface and intracardiac electrocardiogram in a patient with inappropriate defibrillation shocks due to hyperkalemia. Intern Med. 2009;48:1153-1156. 53. Furushima H, Chinushi M, Iijima K, Izumi D, Hosaka Y, Aizawa Y. Significance of early onset and progressive increase of activation delay during premature stimulation in Brugada syndrome. Circ J. 2009;73:1408-1415. 54. Chinushi M, Iijima K, Tagawa M, Komura S, Furushima H, Aizawa Y. Effects of verapamil on anterior ST segment and ventricular fibrillation cycle length in patients with Brugada syndrome. J Electrocardiol. 2009;42:367-373. 55. Iijima K, Chinushi M, Furushima H, Hosaka Y, Izumi D, Aizawa Y. Ventricular fibrillation triggered during and after radiofrequency energy delivery to the site of origin of idiopathic right ventricular outflow tract arrhythmia. Pacing Clin Electrophysiol. 2009;32:406-409. 56. Kimura S, Ito M, Chinushi M, Tanaka K, Tanabe Y, Hosaka Y, Komura S, Okada S, Iijima K, Furushima H, Fuse K, Sato M, Aizawa Y. Preservation of renal function in response to cardiac resynchronization therapy. Circ J. 2008;72:1794-1799. 57. Aizawa Y, Chinushi M, Tagawa M, Furushima H, Okada S, Iijima K, Izumi D, Watanabe H, Komura S. A post-QRS potential in Brugada syndrome: its relation to electrocardiographic pattern and possible genesis. J Am Coll Cardiol. 2008;51:1720-1721. 58. Chinushi M, Hosaka Y, Ikarashi N, Iijima K, Furushima H, Aizawa Y. Automatic R-wave and impedance testing with the modern patient alert system to reduce inappropriate implantable cardioverter defibrillator shocks due to lead fracture. Europace. 2008;10:738-740. 59. Chinushi M, Izumi D, Iijima K, Ahara S, Komura S, Furushima H, Hosaka Y, Aizawa Y. Antiarrhythmic vs. pro-arrhythmic effects depending on the intensity of adrenergic stimulation in a canine anthopleurin-A model of type-3 long QT syndrome. Europace. 2008;10:249-255. 60. Furushima H, Chinushi M, Okamura K, Iijima K, Komura S, Tanabe Y, Okada S, Izumi D, Aizawa Y. Comparison of conduction delay in the right ventricular outflow tract between Brugada syndrome and right ventricular cardiomyopathy: investigation of signal average ECG in the precordial leads. Europace. 2007;9:951-956.

研究テーマ

循環器内科学、心臓電気生理学、医用工学

研究業績（論文）

1. Fujiki S, Iijima K, Nakagawa Y, Takahashi K, Okabe M, Kusano K, Owada S, Kondo Y, Tsujita K, Shimizu W, Tomita H, Watanabe M, Shoda M, Watanabe M, Tokano T, Murohara T, Kaneshiro T, Kato T, Hayashi H, Maemura K, Niwano S, Umemoto T, Yoshida H, Ota K, Tanaka T, Kitamura N, Node K, Minamino T; EMPA ICD investigators.　Effect of empagliflozin on ventricular arrhythmias in patients with type 2 diabetes treated with an implantable cardioverter-defibrillator: the EMPA-ICD trial. Cardiovasc Diabetol. 2024;23:224-.
2. Ikami Y, Izumi D, Fujiki S, Sugiura H, Otsuki S, Suzuki N, Sakaguchi Y, Hakamata T, Hasegawa Y, Yagihara N, Iijima K, Tanaka T, Ishizawa M, Chinushi M, Minamino T, Inomata T. Differences in coagulation responses to vascular injury between uninterrupted dabigatran and apixaban - a clinical prospective randomized study. Heart Rhythm. 2024:S1547-5271
3. Sakaguchi Y, Izumi D, Wada R, Akagawa R, Suzuki N, Hakamata T, Ikami Y, Hasegaw Y, Otsuki S, Yagihara N, Iijima K, Inomata T. Predictors of long-term survival in Japanese patients with heart failure with reduced ejection fraction (HFrEF) treated with cardiac resynchronization therapy-defibrillators (CRT-D). Pacing Clin Electrophysiol. 2023;46:1484-1490.
4. Suzuki N, Otsuki S, Izumi D, Akagawa R, Sakaguchi Y, Hakamata T, Ikami Y, Hasegawa Y, Yagihara N, Iijima K, Chinushi M, Inomata T. Clinical impact of nocturnal ventricular tachyarrythmias in electrical storm. Pacing Clin Electrophysiol. 2022;45:1330-1337.
5. Hakamata T, Otsuki S, Izumi D, Sakaguchi Y, Suzuki N, Ikami Y, Hasegawa Y, Yagihara N, Iijima K, Chinushi M, Fuse K, Inomata T. Clinical impact of ECG changes on oversensing of subcutaneous implantable cardioverter-defibrillators. Heart Rhythm. 2022;19:1704-1711
6. Ikami Y, Izumi D, Hasegawa Y, Suzuki N, Sakaguchi Y, Hakamata T, Otsuki S, Yagihara N, Iijima K, Kashimura T, Chinushi M, Minamino T, Inomata T. The Risk of Ventricular Tachyarrhythmias in Patients with Antimitochondrial Antibodies-Related Noncardiac Diseases. Int Heart J. 2022;63:476-485.
7. Otsuki S, Izumi D, Sakaguchi Y, Suzuki N, Hakamata T, Ikami Y, Hasegawa Y, Yagihara N, Iijima K, Chinushi M, Minamino T, Takayuki I.　Efficacy of antitachycardia pacing alert by remote monitoring of implantable cardioverter-defibrillators for out-of-hospital electrical storm. Pacing Clin Electrophysiol. 2021;44:1675-1682.
8. Hasegawa Y, Watanabe H, Ikami Y, Otsuki S, Iijima K, Yagihara N, Izumi D, Minamino T. Response of the authors regarding article "J point elevation in high precordial leads associated with risk of ventricular fibrillation". Ann Noninvasive Electrocardiol. 2021;26:e12871.
9. Hasegawa Y, Izumi D, Ikami Y, Otsuki S, Yagihara N, Iijima K, Chinushi M, Minamino T.
Progressive increase in activation delay during premature stimulation is related to ventricular fibrillation in Brugada syndrome. J Cardiovasc Electrophysiol. 2021;32:1939-1946.
10. Iijima K, Zhang H, Strachan MT, Huang J, Walcott GP, Rogers JM. The right ventricular insertion promotes the reinitiation of ventricular fibrillation in defibrillation failure. Heart Rhythm. 2021: S1547-5271(21)00053-9. doi: 10.1016/j.hrthm.2021.01.022.
11. Hasegawa Y, Watanabe H, Ikami Y, Otsuki S, Iijima K, Yagihara N, Izumi D, Minamino T. J point elevation in high precordial leads associated with risk of ventricular fibrillation.
Ann Noninvasive Electrocardiol. 2021; 26: e12820. doi: 10.1111/anec.12820.
12. Matsuo Y, Yoshimine F, Fuse K, Suzuki K, Sakamoto T, Iijima K, Ozaki K, Minamino T. Regional disparity in guideline adherence for treatment of chronic heart failure. Intern Med. 2021;60(4):525-532.
13. Fujiki S, Iijima K, Okabe M, Niwano S, Tsujita K, Naito S, Ando K, Kusano K, Kato R, Nitta J, Miura T, Mitsuhashi T, Kario K, Kondo Y, Ieda M, Hagiwara N, Murohara T, Takahashi K, Tomita H, Takeishi Y, Anzai T, Shimizu W, Watanabe M, Morino Y, Kato T, Tada H, Nakagawa Y, Yano M, Maemura K, Kimura T, Yoshida H, Ota K, Tanaka T, Kitamura N, Node K, Aizawa Y, Shimizu I, Izumi D, Ozaki K, Minamino T. On behalf of the EMPA-ICD investigators. Placebo-controlled, double-blind study of empagliflozin (EMPA) and implantable cardioverter-defibrillator (EMPA-ICD) in patients with type 2 diabetes (T2DM): rationale and design. Diabetes Therapy. 2020; 11: 2739-2755
14. Otsuki S, Izumi D, Hasegawa Y, Yagihara N, Iijima K, Minamino T. Suppression of cardiac memory-related severe form of torsades de pointes by landiolol in a patient with congenital long QT syndrome type 2. HeartRhythm Case Rep. 2020; 6: 407-410
15. Furukawa K, Suzuki T, Ishiguro H, Morikawa H, Sonoda K, Iijima K, Ito M, Hanyu O, Sone H. Prevention of postprandial hypotension-related syncope by caffeine in a patient with long-standing diabetes mellitus. Endocr J. 2020. doi: 10.1507/endocrj.EJ19-0370.
16. Sato A, Hasegawa Y, Haniu H, Shiraishi S, Yagihara N, Iijima K, Izumi D, Minamino T. Replacement of an Implantable Cardioverter-Defibrillator (ICD) with a New Standard Subcutaneous ICD System in a Patient with Jervell and Lange-Nielsen Syndrome.
Int Heart J. 2019. doi: 10.1536/ihj.19-076. [Epub ahead of print]
17. Hasegawa Y, Watanabe H, Ikami Y, Otsuki S, Iijima K, Yagihara N, Sato A, Izumi D, Minamino T. Early repolarization and risk of lone atrial fibrillation. J Cardiovasc Electrophysiol. 2019;30:565-568.
18. Sato A, Yagihara N, Hasegawa Y, Otuki S, Iijima K, Izumi D, Minamino T. A Steam Pop Detected by Intracardiac Echocardiography During Catheter Ablation of the Left Ventricular Papillary Muscle. Int Heart J. 2019;60:199-203.
19. Takano T, Tanaka K, Ozaki K, Sato A, Iijima K, Yanagawa T, Izumi D, Ozawa T, Fuse K, Sato M, Tanabe N, Minamino T. Clinical Predictors of Recurrent Ventricular Arrhythmias in Secondary Prevention Implantable Cardioverter Defibrillator Recipients With Coronary Artery Disease　- Lower Left Ventricular Ejection Fraction and Incomplete Revascularization. Circ J. 2018;82:3037-3043.
20. Otuki S, Izumi D, Suda M, Sato A, Hasegawa Y, Yagihara N, Iijima K, Chinushi M, Fuse I, Minamino T.　Effects of Direct Oral Anticoagulants at the Peak Phase, Trough Phase, and After Vascular Injury. J Am Coll Cardiol. 2018;71:102-104.
21. Iijima K, Ishida N, Izumi D, Minamino T. Inappropriate inhibition of biventricular pacing due to diaphragmatic myopotentials amplified by the selectable sensing filter. Europace. 2017.doi: 10.1093/europace/euw372.
22. Otuki S, Hasegawa K, Watanabe H, Katsuumi G, Yagihara N, Iijima K, Sato A, Izumi D, Furushima H, Chinushi M, Aizawa Y, Minamino T. The effects of pure potassium channel blocker nifekalant and sodium channel blocker mexiletine on malignant ventricular tachyarrhythmias. J Electrocardiol. 2017;50:277-281.
23. Zhang H, Iijima K, Huang J, Walcott GP, Rogers JM. Optical Mapping of Membrane Potential and Epicardial Deformation in Beating Hearts. Biophys J. 2016;111:438-451.
24. Chinushi M, Suzuki K, Saitoh O, Furushima H, Iijima K, Izumi D, Sato A, Sugai M, Iwafuchi M. Electrical stimulation-based evaluation for functional modification of renal autonomic nerve activities induced by catheter ablation. Heart Rhythm. 2016;13:1707-1715.
25. Iijima K, Chinushi M, Saitoh O, Hasegawa K, Sonoda K, Yagihara N, Sato A, Izumi D, Watanabe H, Furushima H, Aizawa Y, Minamino T. Frequency characteristics and associations with the defibrillation threshold of ventricular fibrillation in patients with implantable cardioverter defibrillators. Intern Med. 2015;54:1175-1182.
26. Chinushi M, Izumi D, Iijima K, Suzuki K, Furushima H, Saitoh O, Furuta Y, Aizawa Y, Iwafuchi M. Blood pressure and autonomic responses to electrical stimulation of the renal arterial nerves before and after ablation of the renal artery. Hypertension. 2013;61(2):450-456
27. Chinushi M, Iijima K, Sato A, Furushima H. Short-coupling premature ventricular complexes from the left ventricle triggered isoproterenol-resistant electrical storm in a patient with Brugada syndrome. Heart Rhythm. 2013;10:916-920.
28. Sato A, Chinushi M, Iijima K, Izumi D, Furushima H.　Insulation Defects in Riata Implantable Cardioverter-defibrillator Leads.　Intern Med. 2012;51:2689-2694.
29. Sato A, Chinushi M, Suzuki H, Numano F, Hanyu T, Iijima K, Watanabe H, Furushima H. Long QT Syndrome with Nocturnal Cardiac Events Caused by a KCNH2 Missense Mutation (G604S). Intern Med. 2012;51:1857-1860.
30. Chinushi M, Sato A, Iijima K, Suzuki K, Hiroshi F, Izumi D, Watanabe H, Kanae H, Aizawa Y. Exercise-Related QT Interval Shortening with a Peaked T Wave in a Healthy Boy with a Family History of Sudden Cardiac Death. Pacing Clin Electrophysiol. 2012;35:e239-242.
31. Iijima K, Chinushi M, Furushima H, Aizawa Y. Epicardial and endocardial mapping determine most successful site of ablation for ventricular tachyarrhythmias originating from left ventricular summit. Europace. 2012;14:911-912.
32. Furushima H, Chinushi M, Iijima K, Hasegawa K, Sato A, Izumi D, Watanabe H, Aizawa Y. Is the coexistence of sustained ST-segment elevation and abnormal Q waves a risk factor for electrical storm in implanted cardioverter defibrillator patients with structural heart diseases? Europace. 2012;14:675-681.
33. Izumi D, Chinushi M, Iijima K, Furushima H, Hosaka Y, Hasegawa K, Aizawa Y. The peak-to-end of the T wave in the limb ECG leads reflects total spatial rather than transmural dispersion of ventricular repolarization in an anthopleurin-A model of prolonged QT interval. Heart Rhythm. 2012;9:796-803.
34. Sato A, Chinushi M, Iijima K, Watanabe H, Izumi D, Furushima H, Sonoda K, Hasegawa K, Yagihara N, Aizawa Y. An appropriate defibrillation threshold obtained by the combined connection between two shock leads and ICD generator. Intern Med. 2011;50:2815-2818.
35. Sato A, Tanabe Y, Chinushi M, Hayashi Y, Yoshida T, Ito E, Izumi D, Iijima K, Yagihara N, Watanabe H, Furushima H, Aizawa Y. Analysis of J waves during myocardial ischaemia. Europace. 2012;14:715-723.
36. Furushima H, Chinushi M, Iijima K, Izumi D, Hosaka Y, Aizawa Y. Relationship between electroanatomical voltage mapping characteristics and breakout site of ventricular activation in idiopathic ventricular tachyarrhythmia originating from the right ventricular outflow tract septum. J Interv Card Electrophysiol. 2012;33:135-141.
37. Iijima K, Chinushi M, Furushima H, Aizawa Y. Intramural inflammation as a cause of transient ST-segment elevation in a patient of cardiac sarcoidosis. Europace. 2012;14:300-302.
38. Chinushi M, Furushima H, Hosaka Y, Komura S, Sato A, Iijima K, Aizawa Y. Endocardial arrhythmogenic mechanisms of torsades de pointes in patients with the congenital long QT syndrome. Intern Med. 2011;50:1695-1702.
39. Yagihara N, Sato A, Iijima K, Izumi D, Furushima H, Watanabe H, Irie T, Kaneko Y, Kurabayashi M, Chinushi M, Satou M, Aizawa Y. The prevalence of early repolarization in Wolff-Parkinson-White syndrome with a special reference to J waves and the effects of catheter ablation. J Electrocardiol. 2012;45:36-42.
40. Chinushi M, Izumi D, Furushima H, Sato A, Iijima K, Hasegawa K, Aizawa Y. Epicardial scar in a patient with no apparent heart disease. Pacing Clin Electrophysiol. 2012;35:e136-139.
41. Iijima K, Chinushi M, Hasegawa K, Izumi D, Hosaka Y, Furushima H, Aizawa Y. Inappropriate pacing inhibition triggered by QT prolongation due to T wave oversensing in an ICD recipient presenting with long QT syndrome. Intern Med. 2011;50:1021-1024.
42. Chinushi M, Hasegawa K, Iijima K, Furushima H, Izumi D, Sato A, Aizawa Y. Characteristics of j wave-associated idiopathic ventricular fibrillation: role of drugs. Pacing Clin Electrophysiol. 2012;35:e226-230.
43. Tagawa M, Chinushi M, Nakamura Y, Ochiai Y, Sato A, Iijima K, Uchiyama H, Furushima H, Aizawa Y. Recurrence of ventricular fibrillation in a patient with non-type 1 Brugada electrocardiographic morphology. J Cardiol Cases. 2012;6:e17-e19.
44. Chinushi M, Iijima K. Rate control is a better initial treatment for patients with atrial fibrillation and heart failure--rhythm control vs. rate control: which is better in the management of atrial fibrillation? (Rate-side). Circ J. 2011;75:970-978.
45. Chinushi M, Iijima K, Furushima H, Izumi D, Sato A, Yagihara N, Hasegawa K, Watanabe H, Soejima K, Aizawa Y. Suppression of Storms of Ventricular Tachycardia by Epicardial Ablation of Isolated Delayed Potential in Noncompaction Cardiomyopathy. Pacing Clin Electrophysiol. 2011 [Epub ahead of print]
46. Iijima K, Chinushi M, Izumi D, Aizawa Y. Ventricular tachycardia due to intramyocardial fibroma. J Cardiovasc Electrophysiol. 2011;22:825-826.
47. Izumi D, Chinushi M, Iijima K, Ahara S, Komura S, Furushima H, Hosaka Y, Sanada A, Yagihara N, Aizawa Y. Effects of bepridil versus E-4031 on transmural ventricular repolarization and inducibility of ventricular tachyarrhythmias in the dog. Pacing Clin Electrophysiol. 2010;33:950-999.
48. Furushima H, Chinushi M, Iijima K, Sanada A, Izumi D, Hosaka Y, Aizawa Y. Ventricular tachyarrhythmia associated with hypertrophic cardiomyopathy: incidence, prognosis, and relation to type of hypertrophy. J Cardiovasc Electrophysiol. 2010;21:991-999.
49. Iijima K, Chinushi M, Izumi D, Ahara S, Furushima H, Komura S, Hosaka Y, Sanada A, Sato A, Aizawa Y. Effect of bepridil in atrial fibrillation inducibility facilitated by vagal nerve stimulation. - Prevention of vagal nerve activation-induced shortening of the atrial action potential duration -. Circ J. 2010;74:895-902.
50. Komura S, Chinushi M, Furushima H, Hosaka Y, Izumi D, Iijima K, Watanabe H, Yagihara N, Aizawa Y. Efficacy of procainamide and lidocaine in terminating sustained monomorphic ventricular tachycardia. Circ J. 2010;74:864-869.
51. Chinushi M, Hosaka Y, Okada S, Iijima K, Furushima H, Aizawa Y. Delayed pericardial effusion due to perforation of the right ventricular outflow tract by an ICD lead. Intern Med. 2010;49:389-392.
52. Hosaka Y, Chinushi M, Iijima K, Sanada A, Furushima H, Aizawa Y. Correlation between surface and intracardiac electrocardiogram in a patient with inappropriate defibrillation shocks due to hyperkalemia. Intern Med. 2009;48:1153-1156.
53. Furushima H, Chinushi M, Iijima K, Izumi D, Hosaka Y, Aizawa Y. Significance of early onset and progressive increase of activation delay during premature stimulation in Brugada syndrome. Circ J. 2009;73:1408-1415.
54. Chinushi M, Iijima K, Tagawa M, Komura S, Furushima H, Aizawa Y. Effects of verapamil on anterior ST segment and ventricular fibrillation cycle length in patients with Brugada syndrome. J Electrocardiol. 2009;42:367-373.
55. Iijima K, Chinushi M, Furushima H, Hosaka Y, Izumi D, Aizawa Y. Ventricular fibrillation triggered during and after radiofrequency energy delivery to the site of origin of idiopathic right ventricular outflow tract arrhythmia. Pacing Clin Electrophysiol. 2009;32:406-409.
56. Kimura S, Ito M, Chinushi M, Tanaka K, Tanabe Y, Hosaka Y, Komura S, Okada S, Iijima K, Furushima H, Fuse K, Sato M, Aizawa Y. Preservation of renal function in response to cardiac resynchronization therapy. Circ J. 2008;72:1794-1799.
57. Aizawa Y, Chinushi M, Tagawa M, Furushima H, Okada S, Iijima K, Izumi D, Watanabe H, Komura S. A post-QRS potential in Brugada syndrome: its relation to electrocardiographic pattern and possible genesis. J Am Coll Cardiol. 2008;51:1720-1721.
58. Chinushi M, Hosaka Y, Ikarashi N, Iijima K, Furushima H, Aizawa Y. Automatic R-wave and impedance testing with the modern patient alert system to reduce inappropriate implantable cardioverter defibrillator shocks due to lead fracture. Europace. 2008;10:738-740.
59. Chinushi M, Izumi D, Iijima K, Ahara S, Komura S, Furushima H, Hosaka Y, Aizawa Y. Antiarrhythmic vs. pro-arrhythmic effects depending on the intensity of adrenergic stimulation in a canine anthopleurin-A model of type-3 long QT syndrome. Europace. 2008;10:249-255.
60. Furushima H, Chinushi M, Okamura K, Iijima K, Komura S, Tanabe Y, Okada S, Izumi D, Aizawa Y. Comparison of conduction delay in the right ventricular outflow tract between Brugada syndrome and right ventricular cardiomyopathy: investigation of signal average ECG in the precordial leads. Europace. 2007;9:951-956.

研究者

教育活動

【学校法人順天堂】研究者情報データベース

研究業績詳細

飯嶋 賢一（イイジマ ケンイチ）

飯嶋賢一（イイジマケンイチ）